Exacis Biotherapeutics Included on Inside Precision Medicine’s Five RNA Therapeutics Startups to Watch in 2022 List
Five RNA Therapeutics Startups to Watch in 2022
Five RNA Therapeutics Startups to Watch in 2022
Dr. Gregory Fiore, Co-Founder, President and CEO of Exacis Biotherapeutics will serve on a panel exploring the difference between autologous and allogeneic stem cell therapies during the Advanced Therapies Conference.
Dr. Gregory Fiore, Co-Founder, President and CEO of Exacis Biotherapeutics will discuss strategies for optimal positioning of new therapies as a panel member at the Cancer Progress Conference.
Dr. Gregory Fiore, Co-Founder, President and CEO of Exacis Biotherapeutics will join of an expert panel of biotherapeutic leaders to discuss “Aligning Priorities with the Board” during the Longwood Healthcare Leaders Meeting.